BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 606205)

  • 1. Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.
    Demisch L; von der Mühlen H; Bochnik HJ; Seiler N
    Arch Psychiatr Nervenkr (1970); 1977 Dec; 224(4):319-29. PubMed ID: 606205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of platelet monoamine oxidase using three different substrates in patients with alcoholism and schizophrenia.
    Tsuji M
    Folia Psychiatr Neurol Jpn; 1985; 39(4):521-30. PubMed ID: 3833630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.
    Meltzer HY; Arora RC; Jackman H; Pscheidt G; Smith MD
    Schizophr Bull; 1980; 6(2):213-9. PubMed ID: 7375852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tryptamine excretion in chronic schizophrenics with low platelet MAO activity.
    Sullivan JL; Coffey CE; Basuk B; Cavenar JO; Maltbie AA; Zung WW
    Biol Psychiatry; 1980 Feb; 15(1):113-20. PubMed ID: 7357050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some kinetic parameters of platelet monoamine oxidase in chronic schizophrenia.
    Kobes RD; Potkin SG; Wise CD; Bridge TP; Neckers LM; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):179-85. PubMed ID: 298347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity.
    Murphy DL; Donnelly CH; Miller L; Wyatt RJ
    Arch Gen Psychiatry; 1976 Nov; 33(11):1377-81. PubMed ID: 985048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia.
    Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W
    Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase: studies of normal and psychiatric populations in a tropical environment.
    Sengupta N; Datta SC; Sengupta D
    Enzyme; 1981; 26(4):191-200. PubMed ID: 7250095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet monoamine oxidase in a pedigree with schizophrenia: an interlaboratory project.
    Ask AL; Böök JA; Heyden T; Ross SB; Unge C; Wetterberg L; Eiduson S; Kobayashi K
    Clin Genet; 1979 Apr; 15(4):289-99. PubMed ID: 436326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet monoamine oxidase and clinical phenomenology of schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.
    Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM
    Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet monoamine oxidase in chronic schizophrenic patients.
    Berger PA; Ginsburg RA; Barchas JD; Murphy DL; Wyatt RJ
    Am J Psychiatry; 1978 Jan; 135(1):95-9. PubMed ID: 618534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia.
    Bond PA; Cundall RL; Falloon IR
    Br J Psychiatry; 1979 Apr; 134():360-5. PubMed ID: 444786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders.
    Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM
    Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet monoamine oxidase: studies on the rate of heat inactivation in normal and in paranoid and nonparanoid chronic schizophrenic groups.
    Wise CD; Bridge TP; Potkin SG; Wyatt RJ
    Psychiatry Res; 1979 Oct; 1(2):187-90. PubMed ID: 298348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet MAO activity in schizophrenia and other psychiatric illnesses.
    Sullivan J; Stanfield CN; Dackis C
    Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients.
    Owen F; Bourne R; Crow TJ; Johnstone EC; Bailey AR; Hershon HI
    Arch Gen Psychiatry; 1976 Nov; 33(11):1370-3. PubMed ID: 791182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients.
    Davis BA; Yu PH; Carlson K; O'Sullivan K; Boulton AA
    Psychiatry Res; 1982 Feb; 6(1):97-105. PubMed ID: 6120530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophoresis of platelet monoamine oxidase in schizophrenia and manic-depressive illness.
    Belmaker RH; Ebstein R; Rimon R; Wyatt RJ; Murphy DL
    Acta Psychiatr Scand; 1976 Jul; 54(1):67-72. PubMed ID: 952234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.